LGC to acquire NAC from Mercia Asset Management for $23m.

LGC, an international life sciences measurement and testing company, agreed to acquire The Native Antigen Company, a pharmaceutical company, from Mercia Asset Management for $23m. “We are excited to join such a well-respected organisation that shares our purpose and mission, and that will support our diagnostic customers by providing even more world-leading products and services,” Nick Roesen, NAC COO.